Cargando…

Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents

Agitation (excessive motor or verbal activity) can be associated with schizophrenia or bipolar mania, and can further escalate into aggressive behavior and potentially lead to injuries in patients and staff. Medications used to treat agitation include antipsychotics and benzodiazepines, usually admi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Citrome, Leslie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665578/ https://www.ncbi.nlm.nih.gov/pubmed/23723707 http://dx.doi.org/10.2147/TCRM.S31484

Ejemplares similares

Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
por: Faden, Justin, et al.
Publicado: (2019)

Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change
por: Pacciardi, Bruno, et al.
Publicado: (2019)

Inhaled Loxapine for Agitation in Intoxicated Patients: A Case Series
por: Roncero, Carlos, et al.
Publicado: (2017)

Managing Agitation Associated with Schizophrenia and Bipolar Disorder in the Emergency Setting
por: Zeller, Scott L., et al.
Publicado: (2016)

Response to inhaled loxapine in patients with schizophrenia or bipolar I disorder: PANSS-EC responder analyses
por: Zeller, Scott, et al.
Publicado: (2017)

Inhaled Loxapine for the Treatment of Psychiatric Agitation in the Prehospital Setting: A Case Series
por: Cester-Martínez, Armando, et al.
Publicado: (2017)

Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder
por: San, L., et al.
Publicado: (2017)

The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review
por: de Berardis, Domenico, et al.
Publicado: (2017)

Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder: A Prospective Study on the Effects of Time
por: Ferrer, Marc, et al.
Publicado: (2022)

Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
por: Citrome, Leslie, et al.
Publicado: (2022)

Correction to: Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
por: Citrome, Leslie, et al.
Publicado: (2022)

Loxapine to control agitation during weaning from mechanical ventilation
por: Gaudry, Stéphane, et al.
Publicado: (2017)

Effect of Smoking on the Pharmacokinetics of Inhaled Loxapine
por: Takahashi, Lori H., et al.
Publicado: (2014)

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
por: Loebel, Antony, et al.
Publicado: (2015)

LOXAPINE IN THE TREATMENT OF SCHIZOPHRENIA : AN OPEN STUDY
por: Emmanuel, S.A., et al.
Publicado: (1997)

Beneficial effects of loxapine on agitation and breathing patterns during weaning from mechanical ventilation
por: Sztrymf, Benjamin, et al.
Publicado: (2010)

Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection
por: Citrome, Leslie
Publicado: (2009)

Loxapine to control agitation during weaning from mechanical ventilation: a randomized controlled trial
por: Gaudry, S, et al.
Publicado: (2015)

Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder
por: Citrome, Leslie, et al.
Publicado: (2017)

A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder
por: Citrome, Leslie
Publicado: (2006)

Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: protocol for a phase IV, single-arm, open-label trial
por: Gil, Emilio, et al.
Publicado: (2018)

Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens
por: Spyker, Daniel A., et al.
Publicado: (2015)

Clinical Outcomes in Patients Taking Inhaled Loxapine, Haloperidol, or Ziprasidone in the Emergency Department
por: McDowell, Marc, et al.
Publicado: (2019)

Characterizing the experience of agitation in patients with bipolar disorder and schizophrenia
por: Roberts, Jenna, et al.
Publicado: (2018)

Sublingual Dexmedetomidine for the Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder
por: Smith, Colin M., et al.
Publicado: (2023)

Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians
por: Citrome, Leslie, et al.
Publicado: (2022)

Revisiting loxapine: a systematic review
por: Popovic, Dina, et al.
Publicado: (2015)

Loxapine in patient with clozapine-resistant psychosis
por: Erley, Jennifer, et al.
Publicado: (2021)

A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers
por: Cassella, James V., et al.
Publicado: (2015)

The Management of Psychomotor Agitation Associated with Schizophrenia or Bipolar Disorder: A Brief Review
por: Pompili, Maurizio, et al.
Publicado: (2021)

Effects of intravenous loxapine on systemic and brain hemodynamics
por: Lescot, T, et al.
Publicado: (2003)

Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo‐controlled drug–drug interaction study
por: Spyker, Daniel A., et al.
Publicado: (2015)

Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm
por: Citrome, Leslie, et al.
Publicado: (2019)

Role of sublingual asenapine in treatment of schizophrenia
por: Citrome, Leslie
Publicado: (2011)

Schizophrenia relapse, patient considerations, and potential role of lurasidone
por: Citrome, Leslie
Publicado: (2016)

Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia
por: Hard, Marjie L., et al.
Publicado: (2017)

Paliperidone: the evidence of its therapeutic value in schizophrenia
por: Kantrowitz, Joshua, et al.
Publicado: (2007)

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder
por: Citrome, Leslie, et al.
Publicado: (2021)

Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
por: Citrome, Leslie
Publicado: (2018)

Considering Loxapine Instead of Clozapine: A Case Series and Literature Review
por: Shrestha, Shristi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pk80b7oodcohv0ntel5vbtt6rb